Get started
Author

Angela Moses

ORCID: 0009-0009-3211-4356
Observed ORCID: 0009-0009-3211-4356
OpenAlex ID: A5049260472
Comprehensive phenotypic analysis of diverse FOXN1 variants
2023 · Angela Moses, Pratibha Bhalla, et al. · Journal of Allergy and Clinical Immunology · 28
PDF
Innate and adaptive immune features associated with immune-related adverse events
2025 · Shaheen Khan, Venkat S Malladi, et al. · Journal for ImmunoTherapy of Cancer · 21
PDF
Mesenchymal cell replacement corrects thymic hypoplasia in murine models of 22q11.2 deletion syndrome
2022 · Pratibha Bhalla, Qiumei Du, et al. · Journal of Clinical Investigation · 13
PDF
KLF13 promotes SLE pathogenesis by modifying chromatin accessibility of key proinflammatory cytokine genes
2024 · Andrew Wang, Anna-Marie Fairhurst, et al. · Communications Biology · 3
Minoxidil restores thymic growth in 22q11.2 deletion syndrome by limiting Sox9+ chondrocyte expansion
2025 · Pratibha Bhalla, Neha Ahuja, et al. · Journal of Human Immunity · 2
PDF
A human ITPR3 variant causes a dominant negative attenuation of calcium responses with immunodeficiency and growth delay confirmed in a mouse model
2023 · Christian Wysocki, Angela Moses, et al. · Clinical Immunology · 2
Mesenchymal cell replacement corrects thymic hypoplasia in murine models of 22q11.2 deletion syndrome
2023 · Pratibha Bhalla, Qiumei Du, et al. · Journal of Clinical Investigation · 1
PDF
22q11.2 Deletion Syndrome Causes a Sox-9–Mediated Expansion of Chondrocytes Limiting Embryonic Thymus Growth Correctable by Minoxidil
2025 · Nicolai van Oers, Pratibha Bhalla, et al. · Journal of Human Immunity
Calcium Leaking from the Endoplasmic Reticulum Caused by a Human ITPR3 R2524C Variant Causes Immunodeficiency, Ectodermal Dysplasia, and Charcot-Marie-Tooth Syndrome
2025 · Nicolai van Oers, Christian Wysocki, et al. · Journal of Human Immunity
152 Thymus Hypoplasia in 22q11.2DS (DiGeorge): From Mechanism to Restoration
2024 · Pratibha Bhalla, Neha Ahuja, et al. · Clinical Immunology
Thymus Tissue Regeneration in 22q11.2DS Mouse Models (DiGeorge) using Mesenchymal Cell Replacement or Vasodilators
2023 · Pratibha Bhalla, Angela Moses, et al. · Clinical Immunology
Defining the impact of FOXN1 variants with functional assays and reaggregate thymus organ cultures reveals those with loss- and gain- of function and dominant negative consequences
2023 · Angela Moses, Pratibha Bhalla, et al. · Clinical Immunology
Characterization of Human FOXN1 Mutations Uncovers both Loss- and Gain-of-Function Outcomes
2022 · Nicolai S van Oers, Angela Moses, et al. · The Journal of Immunology
22q11.2 Deletion Syndrome Causes a Thymus Hypoplasia Corrected by Mesenchymal Cell Replacement
2022 · Nicolai S van Oers, Pratibha Bhalla, et al. · The Journal of Immunology
Longitudinal Immune and Genomic Monitoring Reveals Signatures of Immune-related Adverse Events in Cancer Patients Receiving Checkpoint Inhibitor Therapy
2020 · Shaheen Khan, Angela Moses, et al. · The Journal of Immunology
Works count: 15
Citation count: 70
H-index: 3
I10-index: 3
Year
Topic
Type